Shuk Leung, McGill University

Research

Latest funding

A prospective study of risk stratification with epigenetic markers to improve clinical management of cervical precancerous lesions
CIHR · 2024 · Co-investigator
$100,000
Short-term patient-derived ovarian cancer organoids for frontline drug sensitivity testing
CIHR · 2023 · Nominated PI
$150,000
Magnetic Resonance Imaging (MRI) and Artificial Intelligence (AI) can improve preoperative malignancy risk prediction of ovarian masses.
CIHR · 2023 · Co-investigator
$150,000

A prospective study of risk stratification with epigenetic markers to improve clinical management of cervical precancerous lesions

Co-investigatorCIHR2024Project Grant - Priority Announcement: Early Detection/Cancer Prevention

Principal investigators: Koushik, Anita; Franco, Eduardo L

Keywords: Cervical Cancer; Cervical Intraepithelial Neoplasia; Dna Methylation; Human Papillomavirus; Risk Stratification; Self-Sampling

$100,000

Short-term patient-derived ovarian cancer organoids for frontline drug sensitivity testing

Nominated PICIHR2023Catalyst Grant: NWHRI: Innovation Fund - Biomedical Discovery Grants

Principal investigators: Leung, Shuk On A

Keywords: Drug Testing; Organoid; Ovarian Cancer

$150,000

Magnetic Resonance Imaging (MRI) and Artificial Intelligence (AI) can improve preoperative malignancy risk prediction of ovarian masses.

Co-investigatorCIHR2023Catalyst Grant: NWHRI: Innovation Fund - Biomedical Discovery Grants

Principal investigators: Reinhold, Caroline

Keywords: Adnexal Masses; Artificial Intelligence; Biomarkers; Detection; Histopathology; Magnetic Resonance Imaging; Ovarian-Adnexal Imaging Reporting System(O-Rads); Ultrasound

$150,000

Ultrasensitive, Multiplex Fluorescence Interference Contrast (FLIC) Diagnostic Device for Early Detection of Cervical Cancer

Principal investigatorSSHRC2023New Frontiers in Research Fund - Exploration

Principal investigators: Leung, Shuk On

Keywords: Cervical cancer; Florescence Interference Contrast; Diagnostic device; Cancer screening; Microfluidic

$199,325

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Mention their CIHR grant from 2023

Subject: Prospective PhD student: Drug Testing Dear Professor Leung, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. Your research on drug testing connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "Short-term patient-derived ovarian cancer organoids for frontline drug sensitivity testing" (2023), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]